Boston Scientific Corporation (NYSE:BSX) went down by -0.56% from its latest closing price compared to the recent 1-year high of $46.28. The company’s stock price has collected -1.58% of loss in the last five trading sessions. Press Release reported on 09/09/21 that Boston Scientific Announces 2021 Investor Day Meeting
Is It Worth Investing in Boston Scientific Corporation (NYSE :BSX) Right Now?
Boston Scientific Corporation (NYSE:BSX) scored a price-to-earnings ratio above its average ratio, recording 120.14 x from its present earnings ratio. Plus, the 36-month beta value for BSX is at 0.88. Opinions of the stock are interesting as 22 analysts out of 31 who provided ratings for Boston Scientific Corporation declared the stock was a “buy,” while 4 rated the stock as “overweight,” 5 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $51.46, which is $6.44 above the current price. BSX currently public float of 1.42B and currently shorts hold a 1.41% ratio of that float. Today, the average trading volume of BSX was 6.37M shares.
BSX’s Market Performance
BSX stocks went down by -1.58% for the week, with a monthly jump of 0.32% and a quarterly performance of 3.93%, while its annual performance rate touched 9.73%. The volatility ratio for the week stands at 2.20% while the volatility levels for the past 30 days are set at 1.82% for Boston Scientific Corporation. The simple moving average for the period of the last 20 days is -1.32% for BSX stocks with a simple moving average of 9.63% for the last 200 days.
Analysts’ Opinion of BSX
Barclays, on the other hand, stated in their research note that they expect to see BSX reach a price target of $51. The rating they have provided for BSX stocks is “Overweight” according to the report published on May 25th, 2021.
Atlantic Equities gave a rating of “Overweight” to BSX, setting the target price at $52 in the report published on April 15th of the current year.
BSX Trading at -0.05% from the 50-Day Moving Average
After a stumble in the market that brought BSX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -4.48% of loss for the given period.
Volatility was left at 1.82%, however, over the last 30 days, the volatility rate increased by 2.20%, as shares sank -0.27% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +1.96% upper at present.
During the last 5 trading sessions, BSX fell by -1.58%, which changed the moving average for the period of 200-days by +30.84% in comparison to the 20-day moving average, which settled at $44.80. In addition, Boston Scientific Corporation saw 22.98% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at BSX starting from Mahoney Michael F, who sale 201,041 shares at the price of $44.57 back on Sep 07. After this action, Mahoney Michael F now owns 2,081,822 shares of Boston Scientific Corporation, valued at $8,959,895 using the latest closing price.
Eddy Jodi Euerle, the SVP, Chief Info & Digital Off. of Boston Scientific Corporation, sale 728 shares at $45.33 during a trade that took place back on Sep 01, which means that Eddy Jodi Euerle is holding 20,419 shares at $33,000 based on the most recent closing price.
Stock Fundamentals for BSX
Equity return is now at value 3.40, with 1.70 for asset returns.